{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:45:43Z","timestamp":1769823943009,"version":"3.49.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yebeh.2019.106590","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T08:55:30Z","timestamp":1573030530000},"page":"106590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"PB","title":["The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP)"],"prefix":"10.1016","volume":"121","author":[{"given":"Jer\u00f3nimo","family":"Auzmendi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enes","family":"Akyuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Lazarowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.106590_bb0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/j.1528-1157.1997.tb06130.x","article-title":"Sudden unexpected death in epilepsy: terminology and definitions","volume":"38","author":"Nashef","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0010","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/epi.12328","article-title":"Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study","volume":"54","author":"Holst","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5698\/1535-7511.17.3.180","article-title":"Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"17","author":"Harden","year":"2017","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.106590_bb0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.0000000000003685","article-title":"Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors","volume":"88","author":"Harden","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106590_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1528-1167.2011.03354.x","article-title":"Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis","volume":"53","author":"Hesdorffer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11940-019-0547-4","article-title":"Risk factors for sudden unexpected death in epilepsy (SUDEP) and their mitigation","volume":"21","author":"Whitney","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2019.106590_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.13234","article-title":"Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs","volume":"57","author":"Tomson","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yebeh.2007.01.005","article-title":"Mortality in epilepsy","volume":"10","author":"Hitiris","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106590_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2005.05.004","article-title":"Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors","volume":"65","author":"T\u00e9llez-Zenteno","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1212\/01.WNL.0000156352.61328.CB","article-title":"Case\u2013control study of SUDEP","volume":"64","author":"Langan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106590_bb0055","article-title":"Drug-resistant epilepsy: from multiple hypotheses to an integral explanation using preclinical resources","author":"P\u00e9rez-P\u00e9rez","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106590_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00004691-199104000-00010","article-title":"Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death","volume":"8","author":"Dasheiff","year":"1991","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0065","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1586\/14737175.7.12.1751","article-title":"Sudden unexpected death in epilepsy","volume":"7","author":"Johnston","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2019.106590_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy","volume":"48","author":"Lazarowski","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0075","series-title":"Progressive heart P-glycoprotein (P-gp) overexpression after experimental repetitive seizures (ERS) associated with fatal status epilepticus (FSE). Is it related with SUDEP?","volume":"vol. 1","author":"Auzmendi","year":"2014"},{"key":"10.1016\/j.yebeh.2019.106590_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.56.4.519","article-title":"Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study","volume":"56","author":"Walczak","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.106590_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1059-1311(02)00352-7","article-title":"Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases","volume":"12","author":"Opeskin","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106590_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2018.12.007","article-title":"Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection","volume":"64","author":"Manolis","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106590_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0100","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/00207454.2018.1466780","article-title":"Sudden unexpected death in epilepsy: ongoing challenges in finding mechanisms and prevention","volume":"128","author":"Ruthirago","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0105","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1474-4422(13)70214-X","article-title":"Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study","volume":"12","author":"Ryvlin","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/B:CEMN.0000012728.19117.73","article-title":"Transient expression of MDR-1\/P-glycoprotein in a model of partial cortical devascularization","volume":"24","author":"Ramos","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1369\/jhc.6A7026.2006","article-title":"Expression of the MDR-1 gene-encoded P-glycoprotein in cardiomyocytes of conscious sheep undergoing acute myocardial ischemia followed by reperfusion","volume":"55","author":"Laguens","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.yebeh.2019.106590_bb0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fnins.2019.00750","article-title":"Convulsive stress mimics brain hypoxia and promotes the P-glycoprotein (P-gp) and erythropoietin receptor overexpression. Recombinant human erythropoietin effect on P-gp activity","volume":"13","author":"Merelli","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ph11010021","article-title":"Pilocarpine-induced status epilepticus is associated with p-glycoprotein induction in cardiomyocytes, electrocardiographic changes, and sudden death","volume":"11","author":"Auzmendi","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.yebeh.2019.106590_bb0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12640-010-9233-8","article-title":"Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats","volume":"20","author":"Merelli","year":"2011","journal-title":"Neurotox Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0135","article-title":"Sudden unexpected death in epilepsy: risk factors, biomarkers, and prevention","volume":"139","author":"DeGiorgio","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.106590_bb0140","article-title":"Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2019.106590_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.legalmed.2017.12.003","article-title":"Circulating miRNAs expression profiling in drug-resistant epilepsy: up-regulation of miR-301a-3p in a case of sudden unexpected death","volume":"31","author":"De Matteis","year":"2018","journal-title":"Leg Med"},{"key":"10.1016\/j.yebeh.2019.106590_bb0150","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1158\/0008-5472.CAN-10-3369","article-title":"MicroRNA-301 mediates proliferation and invasion in human breast cancer","volume":"71","author":"Shi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ejhf.223","article-title":"Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction","volume":"17","author":"Wong","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yebeh.2019.106590_bb0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14715\/cmb\/2017.64.15.8","article-title":"Expression of cardiac inwardly rectifying potassium channels in pentylenetetrazole kindling model of epilepsy in rats","volume":"64","author":"Aky\u00fcz","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"key":"10.1016\/j.yebeh.2019.106590_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 gene expression in brain of patients with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0887-8994(99)00074-0","article-title":"Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy","volume":"21","author":"Lazarowski","year":"1999","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2019.106590_bb0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00007691-200402000-00010","article-title":"Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy","volume":"26","author":"Lazarowski","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2019.106590_bb0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2019.106590_bb0185","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1345\/aph.1E068","article-title":"Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy","volume":"38","author":"Summers","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.yebeh.2019.106590_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2009.02.014","article-title":"Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy","volume":"85","author":"Iannetti","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0195","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1111\/j.1468-1331.2011.03513.x","article-title":"Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil","volume":"18","author":"Pirker","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(13)70109-1","article-title":"P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study","volume":"12","author":"Feldmann","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.11604\/pamj.2015.22.297.7956","article-title":"Phenytoin intoxication with no symptoms correlated with serum drug level: a case study","volume":"22","author":"Avcil","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.yebeh.2019.106590_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00007691-200402000-00010","article-title":"Neuronal MDR-1 gene expression and persistent low levels of anticonvulsants in a child with refractory epilepsy","volume":"26","author":"Lazarowski","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2019.106590_bb0215","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1046\/j.1528-1157.2003.21803.x","article-title":"Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy","volume":"44","author":"Sisodiya","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00019052-200304000-00013","article-title":"Mechanisms of antiepileptic drug resistance","volume":"16","author":"Sisodiya","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1389450033491109","article-title":"Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy","volume":"4","author":"Marroni","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.yebeh.2019.106590_bb0230","first-page":"1","article-title":"Research progress on the role of ABC transporters in the drug resistance mechanism of intractable epilepsy","volume":"2015","author":"Xiong","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.yebeh.2019.106590_bb0235","doi-asserted-by":"crossref","DOI":"10.2174\/1568026619666190412121811","article-title":"ABC transporters in neurological disorders: an important gateway for botanical compounds mediated neuro-therapeutics","volume":"19","author":"Jha","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.yebeh.2019.106590_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0887-8994(03)00407-7","article-title":"Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy","volume":"30","author":"Lazarowski","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157488506778194910","article-title":"Multidrug-resistance (MDR) proteins develops refractory epilepsy phenotype:clinical and experimental evidences","volume":"1","author":"Lazarowski","year":"2006","journal-title":"Curr Drug Ther"},{"key":"10.1016\/j.yebeh.2019.106590_bb0250","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnins.2019.00005","article-title":"Ketogenic diet and epilepsy: what we know so far","volume":"13","author":"D'Andrea Meira","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11910-019-0933-z","article-title":"Intractable generalized epilepsy: therapeutic approaches","volume":"19","author":"Hwang","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2019.106590_bb0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/epi4.12276","article-title":"Clinically indicated electrical stimulation strategies to treat patients with medically refractory epilepsy","volume":"3","author":"Izadi","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2019.106590_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0074-7696(08)62587-5","article-title":"Biophysical aspects of P-glycoprotein-mediated multidrug resistance","volume":"171","author":"Wadkins","year":"1997","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1381612003401163","article-title":"What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance","volume":"6","author":"Roepe","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2019.106590_bb0275","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/ijc.23818","article-title":"Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38","volume":"123","author":"Sauvant","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.yebeh.2019.106590_bb0280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/355830a0","article-title":"Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein","volume":"355","author":"Valverde","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2019.106590_bb0285","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.2174\/1381612811319380006","article-title":"P-glycoprotein contributes to cell membrane depolarization of hippocampus and neocortex in a model of repetitive seizures induced by pentylenetetrazole in rats","volume":"19","author":"Auzmendi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2019.106590_bb0290","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1042\/BST20150125","article-title":"Homology modelling of human P-glycoprotein","volume":"43","author":"Domicevica","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.yebeh.2019.106590_bb0295","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv222","article-title":"The role of multidrug resistance efflux pumps in cancer: revisiting a JNCI publication exploring expression of the MDR1 (P-glycoprotein) gene","volume":"107","author":"Gottesman","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.yebeh.2019.106590_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2014.00041","article-title":"Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function","volume":"4","author":"Sharom","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamem.2016.09.023","article-title":"Diverse relations between ABC transporters and lipids: an overview","volume":"1859","author":"Neumann","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.yebeh.2019.106590_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1388-1981(02)00324-4","article-title":"Transbilayer phospholipid movement and the clearance of apoptotic cells","volume":"1585","author":"Williamson","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2019.106590_bb0315","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/096120339600500531","article-title":"Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications","volume":"5","author":"Bevers","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.yebeh.2019.106590_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmgm.2017.12.022","article-title":"Multiscale molecular dynamics simulations of lipid interactions with P-glycoprotein in a complex membrane","volume":"80","author":"Domicevica","year":"2018","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.yebeh.2019.106590_bb0325","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.celrep.2018.07.095","article-title":"Phosphatidylserine externalization results from and causes neurite degeneration in drosophila","volume":"24","author":"Sapar","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.yebeh.2019.106590_bb0330","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/epi.13827","article-title":"Postictal hypoperfusion\/hypoxia provides the foundation for a unified theory of seizure-induced brain abnormalities and behavioral dysfunction","volume":"58","author":"Farrell","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0335","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2174\/1570159X16666180110130253","article-title":"Understanding the role of hypoxia inducible factor during neurodegeneration for new therapeutics opportunities","volume":"16","author":"Merelli","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:CEMN.0000012726.43842.d2","article-title":"Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model","volume":"24","author":"Lazarowski","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0350","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0355","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.5114\/aoms.2016.62723","article-title":"Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1\u03b1, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes","volume":"13","author":"Badowska-Kozakiewicz","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0360","series-title":"2136-(12-3-17)-AES, Annu Meet","article-title":"Pilocarpine-induced status epilepticus (SE) induces functional and histological P-glycoprotein overexpression in cardiomyocytes, heart dysfunction and high ratio of sudden death in rats","author":"Auzmendi","year":"2017"},{"key":"10.1016\/j.yebeh.2019.106590_bb0365","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.82.5.1826","article-title":"Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence","volume":"82","author":"Piwnica-Worms","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.yebeh.2019.106590_bb0370","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1369\/jhc.4A6542.2005","article-title":"Cardiomyocytes of chronically ischemic pig hearts express the MDR-1 gene-encoded P-glycoprotein","volume":"53","author":"Lazarowski","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.yebeh.2019.106590_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.05.038","article-title":"Comorbidity between epilepsy and cardiac arrhythmias: implication for treatment","author":"Zaccara","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106590_bb0380","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.CIR.66.6.1146","article-title":"The stunned myocardium: prolonged, postischemic ventricular dysfunction","volume":"66","author":"Braunwald","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.yebeh.2019.106590_bb0385","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/hc4801.100038","article-title":"Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1","volume":"104","author":"Kloner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yebeh.2019.106590_bb0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1023092702389","article-title":"Myocardial stunning in man","volume":"8","author":"Barnes","year":"2003","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.yebeh.2019.106590_bb0395","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s003950070021","article-title":"Brief preconditioning ischemia alters diacylglycerol content and composition in rabbit heart","volume":"95","author":"Gysembergh","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s002800000172","article-title":"Selective modulation of P-glycoprotein's ATPase and anion efflux regulation activities with PKC alpha and PKC epsilon in Sf9 cells","volume":"46","author":"Idriss","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvn116","article-title":"Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease","volume":"79","author":"Schwenk","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0410","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/S0022-2275(20)33310-1","article-title":"Membrane transport of long-chain fatty acids: evidence for a facilitated process","volume":"39","author":"Abumrad","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0415","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)33504-5","article-title":"Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles","volume":"40","author":"Luiken","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0420","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2013.07.020","article-title":"Cardiomyocyte-specific ablation of CD36 improves post-ischemic functional recovery","volume":"63","author":"Nagendran","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0425","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1182\/bloodadvances.2018025411","article-title":"Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo","volume":"2","author":"Yang","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.yebeh.2019.106590_bb0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrneurol.2014.64","article-title":"Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention","volume":"10","author":"Massey","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0435","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.108.789081","article-title":"Cardiac ion channels","volume":"2","author":"Grant","year":"2009","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0440","doi-asserted-by":"crossref","first-page":"a022871","DOI":"10.1101\/cshperspect.a022871","article-title":"Potassium channels in epilepsy","volume":"6","author":"K\u00f6hling","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yebeh.2019.106590_bb0445","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.semnephrol.2013.04.004","article-title":"Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis","volume":"33","author":"Cheng","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12508-y","article-title":"Prolonged seizure activity causes caspase dependent cleavage and dysfunction of G-protein activated inwardly rectifying potassium channels","volume":"7","author":"Baculis","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2019.106590_bb0455","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1742-2094-9-280","article-title":"Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 \u03b2","volume":"9","author":"Zurolo","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.yebeh.2019.106590_bb0460","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1179\/1743132813Y.0000000157","article-title":"Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy","volume":"35","author":"Xu","year":"2013","journal-title":"Neurol Res"},{"key":"10.1016\/j.yebeh.2019.106590_bb0465","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccep.2016.01.005","article-title":"Adenosine triphosphate-sensitive potassium currents in heart disease and cardioprotection","volume":"8","author":"Nichols","year":"2016","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.yebeh.2019.106590_bb0470","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/ijms20081979","article-title":"Update on the genetic basis of sudden unexpected death in epilepsy","volume":"20","author":"Coll","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0475","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ebiom.2015.07.005","article-title":"Genome-wide polygenic burden of rare deleterious variants in sudden unexpected death in epilepsy","volume":"2","author":"Leu","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yebeh.2019.106590_bb0480","first-page":"5523","article-title":"Editorial. Channelopathies: a link between brain and heart: the model of epilepsy","volume":"21","author":"Iannetti","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0485","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1528-1167.2005.59204.x","article-title":"Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus","volume":"46","author":"Iannetti","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.106590_bb0490","first-page":"1551","article-title":"A new type of periodic paralysis: Andersen-Tawil syndrome","volume":"192","author":"Pouget","year":"2008","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.yebeh.2019.106590_bb0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2009.08.013","article-title":"Cardiac strong inward rectifier potassium channels","volume":"48","author":"Anumonwo","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yebeh.2019.106590_bb0500","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fncel.2013.00104","article-title":"Expressional analysis of the astrocytic Kir4.1 channel in a pilocarpine\u2013induced temporal lobe epilepsy model","volume":"7","author":"Nagao","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fncel.2016.00081","article-title":"Potassium channels and human epileptic phenotypes: an updated overview","volume":"10","author":"Villa","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0510","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/ijms20051013","article-title":"Down-regulation of astrocytic Kir4.1 channels during the audiogenic epileptogenesis in leucine-rich glioma-inactivated 1 (Lgi1) mutant rats","volume":"20","author":"Kinboshi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2019.106590_bb0520","article-title":"P-glycoprotein expression in heart, and its potential physiological relevance","volume":"10","author":"Lazarowski","year":"2018","journal-title":"J Cardiol Cardiovasc Ther"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019307991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019307991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:40:29Z","timestamp":1761504029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019307991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":103,"alternative-id":["S1525505019307991"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106590","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP)","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106590"}}